Switzerland· 51181002
Lodine retard 600 mg, Filmtabletten
A etodolac product, registered in Switzerland by Alfasigma Schweiz AG and dispensed under Swissmedic category B. The same ATC class is registered in 7 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Etodolac is registered in 7 of 19 countries.
Countries holding a registration under ATC M01AB08 (etodolac), each read from that country’s own register.
- This record: Switzerland
- 4 of them publish a price we can compare per daily dose
Etodolac · ATC M01AB08
7 / 19 countries
- Denmark
- Finlandprice
- Franceprice
- Japan
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of etodolac costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $0.43 in France to $0.80 in Switzerland — a ×1.9 gap.
- Switzerland: $0.80 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Etodolac · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$0.80
- FR France$0.43
The record
At a glance
- Manufacturer
- Alfasigma Schweiz AG
- Country
- Switzerland (CH)
- ATC code
- M01AB08
- ATC class
- Etodolac
- Defined daily dose
- 0.4 g, O
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
368 interactions on record for etodolac.
Graded by severity as the source publishes them — 57 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Etodolac · interactions on record
368 records
- 57 severe
- 140 moderate
- 5 minor
- 85 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
81 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under M01AB08
Etodolac, as other registers publish it.
- United KingdomEbretin 200mg capsulesSun Pharma UK Ltd
- United KingdomEbretin 300mg capsulesSun Pharma UK Ltd
- United KingdomEccoxolac 300mg capsulesMeda Pharmaceuticals Ltd
- United StatesetodolacIpca Laboratories Limited
- United StatesetodolacIpca Laboratories Limited
- United StatesetodolacIpca Laboratories Limited
- United StatesetodolacA-S Medication Solutions
- United StatesetodolacIpca Laboratories Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa57c85b-dc09-4249-a2ab-7aaac0e5364b GET /v1/drugs/aa57c85b-dc09-4249-a2ab-7aaac0e5364b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about etodolac.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.